Wondering about 5 amino 1mq peptide dosage? No human dose is established. Here's what preclinical studies and community protocols report, plus safety notes.
There is no established human dosage for 5-amino-1MQ. The compound has not been approved by the FDA for human use, and no published clinical trial has defined a safe or effective dose in people. Most of what circulates online mixes rodent data with anecdotal reports from research-chemical users, and those two sources are not interchangeable.
What Is 5-Amino-1MQ?
5-amino-1MQ is a small molecule that inhibits nicotinamide N-methyltransferase (NNMT), an enzyme involved in NAD+ metabolism and methylation reactions. Despite how it is marketed, 5-amino-1MQ is not a peptide — it is a quinolinium-based compound that gets grouped with peptides because of where it is sold.
Rodent research has linked NNMT inhibition to lower fat mass, improved glucose tolerance, and changes in energy expenditure. Those results are genuinely interesting, but they were produced in mice, not humans.
What Preclinical Studies Actually Used
Animal research reports dose as milligrams per kilogram of body weight, typically given once daily by injection or blended into feed. Mouse protocols generally fall in the low single-digit mg/kg range.
That figure cannot be copied onto a human scale. Species differ in absorption, distribution, and clearance, so any conversion is a rough estimate rather than a clinical recommendation.
| Dosing context | Amount reported | Route | Evidence quality |
|---|---|---|---|
| Mouse studies | Low single-digit mg/kg per day | Injection or diet | Peer-reviewed, animal-only |
| Community reports (oral) | Commonly 50–150 mg per day | Capsule or liquid | Anecdotal, unverified |
| Community reports (injection) | Commonly 50–100 mg per day | Subcutaneous | Anecdotal, unverified |
| Human clinical dose | None established | Not applicable | No human trials published |
Reported ranges for 5-amino-1mq dosage per day vary enormously from one forum post to the next, which is itself a sign that no reliable standard exists.
Why Reported Human Dosages Are Anecdotal
There is no pharmacokinetic data for 5-amino-1MQ in humans. Nobody knows its human half-life, its oral bioavailability, or how much of a capsule reaches circulation intact.
Vendor pages and forum threads repeat numbers without citing a study, and those numbers are often copied from one site to the next. Purity and actual content of research chemicals also vary widely between suppliers.
Many people who look into 5-amino-1mq peptide benefits are working from the same handful of mouse papers, which is a thin foundation for any dosing decision.
Oral vs. Subcutaneous Use
Discussions of 5-amino-1mq dosage subcutaneous center on a single daily injection, usually because users assume injections bypass digestion. That assumption is plausible but unproven for this compound.
An oral route is simpler and carries no injection-site risk, but gut absorption is completely unmeasured.
| Route | How it is used | Main unknowns |
|---|---|---|
| Oral | Capsules or liquid, once daily | Bioavailability and first-pass metabolism are unknown |
| Subcutaneous | Injected once daily into abdominal fat | No human absorption or clearance data; injection-site irritation possible |
What a Dosage Calculator Can and Cannot Do
A 5-amino-1mq dosage calculator is usually just a body-weight multiplier. You enter your weight in kilograms and a mg/kg figure, and it returns a daily milligram amount.
The arithmetic is fine. The problem is the input — the mg/kg number comes from mice, so the output looks precise while resting on an unverified assumption.
Calculators also ignore factors like kidney and liver function, other medications, and body composition, all of which affect how any compound is handled.
Is There a Real 5-Amino-1MQ Protocol?
No published 5-amino-1mq dosage protocol exists for humans. A real protocol normally includes dose, frequency, duration, monitoring, and stopping criteria; none of these have been defined for this compound.
Any schedule you find online is one person's experiment rather than a standard of care. Cycle length, bloodwork, and follow-up are left entirely to the user, which is one reason clinician supervision matters.
Safety, Side Effects, and Legal Status
5-amino-1MQ is sold as a research chemical labeled "not for human consumption," and it is not an approved drug in the United States. That means no regulated manufacturing standards, no required purity testing, and no reporting system for adverse events.
Because NNMT is involved in methylation and NAD+ balance, long-term inhibition could plausibly affect pathways beyond fat metabolism. Whether that matters in humans is unknown.
Community-reported issues are mostly vague, such as injection-site irritation, headache, and fatigue. Absence of reported harm is not evidence of safety, and anyone considering this compound should speak with a licensed healthcare professional first.
The Bottom Line
There is no known safe or effective 5-amino-1MQ dose for humans, and no clinical trial has established one. Mouse studies used body-weight-scaled doses that do not translate directly to people.
Community figures in the 50–150 mg per day range are repeated widely but remain unverified. If you discuss this with a clinician, bring the preclinical papers rather than forum screenshots.
Frequently Asked Questions
What is the typical 5 amino 1mq peptide dosage?
No established human dosage exists. Preclinical mouse studies dose by body weight in the low single-digit mg/kg range, while online community reports commonly repeat figures between 50 mg and 150 mg per day. Neither is a validated human dose, and the compound is not FDA-approved for human use.
Is 5-amino-1MQ actually a peptide?
No. 5-amino-1MQ is a small molecule NNMT inhibitor, not a peptide, even though it is sold and discussed alongside peptides. It gets grouped with them mainly because of marketing and the catalogs where it appears.
Is 5-amino-1MQ FDA-approved for weight loss?
No. 5-amino-1MQ is not approved by the FDA for any human use and is sold strictly as a research chemical for laboratory purposes. That means there is no approved dose, no regulated manufacturing standard, and no safety monitoring system.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.